Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Southwestern Oncology Group pretreatment risk criteria as predictive or prognostic factors in acute myeloid leukemia.
Espirito Santo A, Chacim S, Ferreira I, Leite L, Moreira C, Pereira D, Dantas M, Nunes M, Viterbo L, Moreira I, Martins A, Oliveira I, Domingues N, Mariz J, Medeiros R. Espirito Santo A, et al. Among authors: viterbo l. Mol Clin Oncol. 2017 Mar;6(3):384-388. doi: 10.3892/mco.2017.1134. Epub 2017 Jan 20. Mol Clin Oncol. 2017. PMID: 28451418 Free PMC article.
Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution.
Cerveira N, Lisboa S, Correia C, Bizarro S, Santos J, Torres L, Vieira J, Barros-Silva JD, Pereira D, Moreira C, Meyer C, Oliva T, Moreira I, Martins Â, Viterbo L, Costa V, Marschalek R, Pinto A, Mariz JM, Teixeira MR. Cerveira N, et al. Among authors: viterbo l. Mol Oncol. 2012 Oct;6(5):553-64. doi: 10.1016/j.molonc.2012.06.004. Epub 2012 Jul 14. Mol Oncol. 2012. PMID: 22846743 Free PMC article.
Effect of therapy-related acute myeloid leukemia on the outcome of patients with acute myeloid leukemia.
ESPíRITO Santo AE, Chacim S, Ferreira I, Leite L, Moreira C, Pereira D, Dantas Brito MD, Nunes M, Domingues N, Oliveira I, Moreira I, Martins A, Viterbo L, Mariz JM, Medeiros R. ESPíRITO Santo AE, et al. Among authors: viterbo l. Oncol Lett. 2016 Jul;12(1):262-268. doi: 10.3892/ol.2016.4591. Epub 2016 May 17. Oncol Lett. 2016. PMID: 27347135 Free PMC article.
Discontinuation of tyrosine kinase inhibitors in CML patients in real-world clinical practice at a single institution.
Cerveira N, Loureiro B, Bizarro S, Correia C, Torres L, Lisboa S, Vieira J, Santos R, Pereira D, Moreira C, Chacim S, Domingues N, Espírito-Santo A, Oliveira I, Moreira I, Viterbo L, Martins Â, Teixeira MR, Mariz JM. Cerveira N, et al. Among authors: viterbo l. BMC Cancer. 2018 Dec 12;18(1):1245. doi: 10.1186/s12885-018-5167-y. BMC Cancer. 2018. PMID: 30541488 Free PMC article.
Gastric Diffuse Large B-Cell Lymphoma: A Single-Center 9-Year Experience.
Couto ME, Oliveira I, Domingues N, Viterbo L, Martins Â, Moreira I, Espírito-Santo A, Chacim S, Moreira C, Pereira D, Henrique R, Mariz J. Couto ME, et al. Among authors: viterbo l. Indian J Hematol Blood Transfus. 2021 Jul;37(3):492-496. doi: 10.1007/s12288-020-01391-9. Epub 2021 Jan 2. Indian J Hematol Blood Transfus. 2021. PMID: 33424149 Free PMC article.
Gastric MALT Lymphoma: A 8-Year Experience.
Couto ME, Oliveira I, Domingues N, Viterbo L, Martins Â, Moreira I, Espírito Santo A, Chacim S, Moreira C, Pereira D, Henrique R, Mariz J. Couto ME, et al. Among authors: viterbo l. Indian J Hematol Blood Transfus. 2022 Jul;38(3):492-498. doi: 10.1007/s12288-021-01483-0. Epub 2021 Aug 26. Indian J Hematol Blood Transfus. 2022. PMID: 35747568 Free PMC article.
Patient-reported health-related quality of life from the phase III TOURMALINE-MM1 study of ixazomib-lenalidomide-dexamethasone versus placebo-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma.
Leleu X, Masszi T, Bahlis NJ, Viterbo L, Baker B, Gimsing P, Maisnar V, Samoilova O, Rosiñol L, Langer C, Song K, Izumi T, Cleeland C, Berg D, Lin HM, Zhu Y, Skacel T, Moreau P, Richardson PG. Leleu X, et al. Among authors: viterbo l. Am J Hematol. 2018 May 4. doi: 10.1002/ajh.25134. Online ahead of print. Am J Hematol. 2018. PMID: 29726031 Free article.
Ixazomib significantly prolongs progression-free survival in high-risk relapsed/refractory myeloma patients.
Avet-Loiseau H, Bahlis NJ, Chng WJ, Masszi T, Viterbo L, Pour L, Ganly P, Palumbo A, Cavo M, Langer C, Pluta A, Nagler A, Kumar S, Ben-Yehuda D, Rajkumar SV, San-Miguel J, Berg D, Lin J, van de Velde H, Esseltine DL, di Bacco A, Moreau P, Richardson PG. Avet-Loiseau H, et al. Among authors: viterbo l. Blood. 2017 Dec 14;130(24):2610-2618. doi: 10.1182/blood-2017-06-791228. Epub 2017 Oct 20. Blood. 2017. PMID: 29054911 Free article. Clinical Trial.
25 results